Developer docs
API playgroundTry for free, no card

Search company profiles

DeNovo Ventures

Full company profile

uuid0009ksc

Namestring
DeNovo Ventures
Websiteurl
denovovc.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

DeNovo Ventures is a privately held venture capital firm founded in 2000 and based in Saratoga, California. According to its firmographic profile, the firm was formed by seasoned investors and experienced medical device entrepreneurs who sought to share the lessons of operating in the medical device sector, indicating a thematic specialization in medical device and healthcare investing rather than generalist venture investing.

The firm operates with a small, partner-led team of one to ten employees. Its leadership comprises co-founders and managing directors David M. Mauney and Richard Ferrari, managing directors Frederick Dotzler, Jay Watkins, and Joe Mandato, and Paul Cioni as Executive Vice President of Operations and CTO. The combination of investor and former-operator backgrounds is positioned as the firm's core differentiation.

The business model follows standard venture capital economics: the firm raises capital from limited partners and invests in early-stage medical device companies, generating revenue primarily through management fees and, when successful, carried interest on portfolio realizations. The firm's own web presence is minimal — its public site consists of a tracking pixel and a privacy opt-out link — providing no additional disclosure on fund size, portfolio composition, AUM, or recent investment activity.

Short descriptiontext

DeNovo Ventures is a small, privately held venture capital firm founded in 2000 in Saratoga, California that invests in medical device companies, leveraging the operating and investing experience of its six-person partner team.

Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersSaratoga, United States
HQ citystring
Saratoga
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
venture capital, medical device investing, early-stage funding, growth equity, healthcare venture capital
Industry1 code
1Corporate Innovation & Technology Scouting Units (with investment mandate)
CodeFSANAHAIPrimaryYes
NAICS code2 codes
  • Management Consulting Services54161
  • Securities, Commodity Contracts, and Other Financial Investments and Related Activities523
SIC code2 codes
  • Services-Management Consulting Services8742
  • Investment Advice6282
Product category
Venture Capital — Medical Device Investment
No data
Cost components2 values
Personnel, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

DeNovo Ventures is a venture capital firm that invests in medical device companies. Founded in 2000 by seasoned investors and experienced medical device entrepreneurs, the firm provides equity capital and operational guidance to early-stage and growth-stage medical device businesses. It is based in Saratoga, United States, and operates with a small team of professionals.

Differentiator
Functional benefit
Problem solved
Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Long-standing healthcare and medical device venture firm. Direct comparable to DeNovo in terms of sector specialization and historical vintage span.

TypeDirect peer
Description

Healthcare-dedicated venture capital firm investing across medical devices, biopharma, and diagnostics. Closest comparable to DeNovo given its healthcare-specialist thesis and multi-stage investment approach.

TypeDirect peer
Description

Healthcare-focused venture firm with deep medical device and diagnostics investing experience. Operates as a specialist GP comparable in scope and orientation to DeNovo Ventures.

TypeDirect peer
Description

Healthcare-dedicated venture and growth equity firm with long history of medical device and biotechnology investing. Directly comparable specialist GP to DeNovo.

TypeBroad incumbent
Description

Large multi-stage venture firm with a substantial healthcare and medical device practice. A broader incumbent that competes for similar deals but operates across many sectors.

TypeDirect peer
Description

Venture and growth equity firm exclusively focused on medical technology and medical devices. Highly comparable specialist thesis and stage focus to DeNovo Ventures.

TypeDirect peer
Description

Medical device-focused growth equity and venture firm. Similar specialist orientation, providing growth capital to commercial-stage medical technology companies.

TypeRegional player
Description

Europe-based healthcare and medtech venture firm. Comparable medtech-specialist thesis but primarily serves European entrepreneurs, with limited direct overlap with DeNovo's US-centric deal flow.

TypeBroad incumbent
Description

Multi-sector private equity and venture firm with an active healthcare practice. Overlaps with DeNovo in medical device deal sourcing but operates as a broader platform.

TypeBroad incumbent
Description

Healthcare-focused strategic investment platform affiliated with Ascension Health. Invests across medical devices and digital health, providing a corporate-strategic peer comparable to DeNovo's healthcare focus.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment103 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

DeNovo Ventures

Venture Capital — Medical Device Investmentdenovovc.com

DeNovo Ventures is a small, privately held venture capital firm founded in 2000 in Saratoga, California that invests in medical device companies, leveraging the operating and investing experience of its six-person partner team.

What DeNovo Ventures does

DeNovo Ventures is a privately held venture capital firm founded in 2000 and based in Saratoga, California. According to its firmographic profile, the firm was formed by seasoned investors and experienced medical device entrepreneurs who sought to share the lessons of operating in the medical device sector, indicating a thematic specialization in medical device and healthcare investing rather than generalist venture investing.

The firm operates with a small, partner-led team of one to ten employees. Its leadership comprises co-founders and managing directors David M. Mauney and Richard Ferrari, managing directors Frederick Dotzler, Jay Watkins, and Joe Mandato, and Paul Cioni as Executive Vice President of Operations and CTO. The combination of investor and former-operator backgrounds is positioned as the firm's core differentiation.

The business model follows standard venture capital economics: the firm raises capital from limited partners and invests in early-stage medical device companies, generating revenue primarily through management fees and, when successful, carried interest on portfolio realizations. The firm's own web presence is minimal — its public site consists of a tracking pixel and a privacy opt-out link — providing no additional disclosure on fund size, portfolio composition, AUM, or recent investment activity.

DeNovo Ventures firmographics

Firmographics
Name
DeNovo Ventures
Website
https://denovovc.com
Company type
Private
Founded year
2000
Headcount range
251–500 employees
Short description
DeNovo Ventures is a small, privately held venture capital firm founded in 2000 in Saratoga, California that invests in medical device companies, leveraging the operating and investing experience of its six-person partner team.
Ownership category
akta.pro rank

DeNovo Ventures industry classification

Industry
Product category
Venture Capital — Medical Device Investment
NAICS
Management Consulting Services (54161), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)
SIC
Services-Management Consulting Services (8742), Investment Advice (6282)
akta.pro primary industry
Corporate Innovation & Technology Scouting Units (with investment mandate) (FSANAHAI)

Keywords

  • Venture capital
  • Medical device investing
  • Early-stage funding
  • Growth equity
  • Healthcare venture capital

Where DeNovo Ventures is headquartered

Location

Headquarters

HQ city
Saratoga
HQ country
United States
HQ region
North America

Markets served

DeNovo Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations

DeNovo Ventures product offering

Product offering

Core offering

DeNovo Ventures is a venture capital firm that invests in medical device companies. Founded in 2000 by seasoned investors and experienced medical device entrepreneurs, the firm provides equity capital and operational guidance to early-stage and growth-stage medical device businesses. It is based in Saratoga, United States, and operates with a small team of professionals.

Differentiator

Problem solved

Functional benefit

Companies that use DeNovo Ventures

Customer profile

Ideal customer profiles1 record

DeNovo Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

DeNovo Ventures partnerships and signals

Strategic signal

Recent moves2 records

Expansion highlights2 records

DeNovo Ventures competitors and assessment

Company assessment

Direct peers

  • Domain Associates: Long-standing healthcare and medical device venture firm. Direct comparable to DeNovo in terms of sector specialization and historical vintage span.
  • OrbiMed Advisors: Healthcare-dedicated venture capital firm investing across medical devices, biopharma, and diagnostics. Closest comparable to DeNovo given its healthcare-specialist thesis and multi-stage investment approach.
  • Versant Ventures: Healthcare-focused venture firm with deep medical device and diagnostics investing experience. Operates as a specialist GP comparable in scope and orientation to DeNovo Ventures.
  • SV Health Investors: Healthcare-dedicated venture and growth equity firm with long history of medical device and biotechnology investing. Directly comparable specialist GP to DeNovo.
  • Vensana Capital: Venture and growth equity firm exclusively focused on medical technology and medical devices. Highly comparable specialist thesis and stage focus to DeNovo Ventures.
  • SightLine Partners: Medical device-focused growth equity and venture firm. Similar specialist orientation, providing growth capital to commercial-stage medical technology companies.

Broad incumbents

  • New Enterprise Associates (NEA): Large multi-stage venture firm with a substantial healthcare and medical device practice. A broader incumbent that competes for similar deals but operates across many sectors.
  • Baird Capital: Multi-sector private equity and venture firm with an active healthcare practice. Overlaps with DeNovo in medical device deal sourcing but operates as a broader platform.
  • Ascension Ventures: Healthcare-focused strategic investment platform affiliated with Ascension Health. Invests across medical devices and digital health, providing a corporate-strategic peer comparable to DeNovo's healthcare focus.

Regional players

  • Sofinnova Partners: Europe-based healthcare and medtech venture firm. Comparable medtech-specialist thesis but primarily serves European entrepreneurs, with limited direct overlap with DeNovo's US-centric deal flow.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

DeNovo Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

DeNovo Ventures leadership team

Management profile

Number of profiles

Profiles6 records

DeNovo Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

DeNovo Ventures M&A and investment

M&A and investment

M&A

Investments103 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DeNovo Ventures

What does DeNovo Ventures do?

DeNovo Ventures is a venture capital firm that invests in medical device companies. Founded in 2000 by seasoned investors and experienced medical device entrepreneurs, the firm provides equity capital and operational guidance to early-stage and growth-stage medical device businesses. It is based in Saratoga, United States, and operates with a small team of professionals.

When was DeNovo Ventures founded?

DeNovo Ventures was founded in 2000. It employs 251 to 500 people.

Where is DeNovo Ventures based?

DeNovo Ventures is headquartered in Saratoga, United States, in the North America region.

Who are DeNovo Ventures's main competitors?

Direct peers on record are Domain Associates, OrbiMed Advisors, Versant Ventures, SV Health Investors, Vensana Capital and SightLine Partners. Broad incumbents are New Enterprise Associates (NEA), Baird Capital and Ascension Ventures. Sofinnova Partners is listed as a regional player.

Does DeNovo Ventures have an API?

No public API is recorded for DeNovo Ventures.

What industry is DeNovo Ventures in?

DeNovo Ventures's product category is Venture Capital — Medical Device Investment. Its primary akta.pro industry code is FSANAHAI, Corporate Innovation & Technology Scouting Units (with investment mandate). Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireHeartBeam Appoints Rich Ferrari and Marga Ortigas-Wedekind to its Board of DirectorsHeartBeam, Inc., a cardiac diagnostic mHealth company based in Santa Clara, California, announced the expansion of its Board of Directors with the appointments of Rich Ferrari and Marga Ortigas-Wedekind. Rich Ferrari is a Silicon Valley venture capitalist and co-founder of De Novo Ventures, which manages $650 million dedicated to medical devices and biotechnology, and brings prior experience as CEO of two publicly traded medical technology companies. Marga Ortigas-Wedekind is a marketing executive with 30 years of leadership experience in medical and health technology companies including iRhythm Technologies and Omnicell. According to the CEO, their involvement is expected to positively impact the company as it approaches FDA submission and commercialization of its 12-lead capable ECG technology.FinSMEsSpinal Modulation Closes $30M Series D FinancingSpinal Modulation, a Menlo Park-based spinal cord stimulator developer, closed a $30M Series D financing. Investors include Medtronic, DeNovo Ventures, and others. The company will use the funds for clinical trials and to begin commercialization outside the U.S.FinSMEsTRIA Beauty Raises $15.6MTRIA Beauty, a Dublin, California-based light-based beauty solutions provider, raised $15.6M in a preferred stock financing. Investors include Aisling Capital, De Novo Ventures, Technology Partners, and Vivo Ventures. The company will use the capital to expand worldwide commercialization, focusing on Asia.FinSMEsArticulinx Closes $10M Series B FinancingArticulinx, a medical device company, closed a $10M Series B financing led by US Venture Partners, with De Novo Ventures participating. The funds will support development of its Articulinx spacer technology and ongoing operations. The company's first product, the Articulinx CMC Spacer, is implanted through a small incision under local anesthesia.